HIGHLIGHTS
- who: Junhyung Kim from the Fudan University, China have published the research: Clinicopathologic Characteristics of Grade 2/3 Meningiomas: Au0092Perspective on the Role of Next-Generation Sequencing, in the Journal: (JOURNAL)
- what: TERT Promoter Mutation Analysis by Pyrosequencing This study was intended for patients with intracranial meningioma. This study demonstrated the clinical, histopathologic, and genomic characteristics of grade 2/3 meningiomas.
- how: The authors explored the clinical significance of molecular diagnostic studies in grade 2/3 meningiomas.
- future: Future investigations should focus more on specific populations of patients with highly malignant . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.